PharmaShots Weekly Snapshot (Oct 5-9, 2020)

 PharmaShots Weekly Snapshot (Oct 5-9, 2020)

PharmaShots Weekly Snapshot (Oct 5-9, 2020)

Takeda Signs ~$1B Pact with Arrowhead for ARO-AAT Targeting Alpha-1 Antitrypsin-Associated Liver Disease   

Published: Oct 9, 2020 | Tags: Alpha-1 Antitrypsin-Associated Liver Disease, Arrowhead, Collaborates, Commercialize. ARO-AAT, Develop, Takeda, with

Lilly and Incyte’s Olumiant (baricitinib) Reports Additional Data Demonstrating Reduction in COVID-19 Recovery Time 

Published: Oct 9, 2020 | Tags: COVID-19, Demonstrate, Incyte, Lilly, Olumiant, Recovery Time, Reduction

Genentech Collaborates with Imbio to Develop Imaging Diagnostics for Lung Diseases

Published: Oct 9, 2020 | Tags: Agreement, Develop, Diagnostics, Diseases, Genentech, Imaging, Imbio, Lung, Signs

Regeneron Seeks the US FDA’s EUA for REGN-COV2 Antibody Combination to Treat COVID-19 

Published: Oct 9, 2020 | Tags: Approve, COVID-19, Emergency, Regeneron, REGN-COV2, Seeks, Use, USFDA

Amgen Report Mixed Results of Omecamtiv Mecarbil in P-lll GALACTIC-HF Study for Heart Failure  

Published: Oct 9, 2020 | Tags: Amgen, GALACTIC-HF Study, Heart Failure, Omecamtiv Mecarbil, P-lll, Report, results

J&J to Supply EU with up to 400M Doses of its COVID-19 Vaccine

Published: Oct 9, 2020 | Tags: 200M Doses, Advance Purchase Agreement, EU, J&J, Janssen COVID-19 Vaccine, Candidate

BioMarin Receives the US FDA’s Approval Allowing Maximum Dose of 60mg with Palynziq (pegvaliase-pqpz) for PKU

Published: Oct 8, 2020 | Tags: BioMarin, Palynziq, pegvaliase-pqpz, Phenylketonuria (PKU), US FDA Approval

BMS’ Zeposia (ozanimod) Receives Health Canada Approval for Relapsing Remitting Multiple Sclerosis

Published: Oct 8, 2020 | Tags: (ozanimod), BMS, Health Canada Approval, Relapsing Remitting Multiple Sclerosis, Zeposia

Eli Lilly Seeks the US FDA’s EUA for its COVID-19 Antibody Treatment 

Published: Oct 8, 2020 | Tags: Antibody Treatment, COVID-19, Eli Lilly, EUA, FDA, Seeks, US

Eli Lilly Collaborates with Dexcom for Diabetes Management

Published: Oct 8, 2020 | Tags: DexCom, Diabetes, Help, Improve, Lilly, Management, New, Program, Teams

Polarean Reports the NDA Submission of Hyperpolarised 129Xenon Gas Drug-Device Diagnostic to the US FDA for Lung Imaging

Published: Oct 8, 2020 | Tags: (129Xe) gas, hyperpolarised, Lung Imaging, NDA submission, Polarean, reports, Us FDA

BMS Report Results of Opdivo (nivolumab) + CT in P-III CheckMate-816 Trial for Resectable Non-Small Cell Lung Cancer 

Published: Oct 8, 2020 | Tags: BMS, CheckMate-816, CT, Nivolumab, Opdivo, P-III, Report, Resectable Non-Small Cell Lung Cancer, results, Trial

PhaseBio Reports First Patients Dosing in its P-III REVERSE-IT Study of Bentracimab in Canada 

Published: Oct 7, 2020 | Tags: Antiplatelet Effects, Bentracimab, Dosing, Generics, PhaseBio, REVERSE-IT Study, ticagrelor

GSK Signs an Agreement with Vir Biotechnology to Develop Solutions for Coronaviruses  

Published: Oct 7, 2020 | Tags: Agreement, Collaboration, Coronavirus, GSK, Immune System Stimulation, Pathogen Neutralization, vaccine, Vir Biotechnology

BioNTech and Pfizer Initiates Rolling Submission to EMA for SARS-CoV-2 Vaccine Candidate, BNT162b2   

Published: Oct 7, 2020 | Tags: BioNTech, BNT162b2, Candidate, EMA, Pfizer, reports, Rolling Submission, SARS-CoV-2, vaccine

Merck Signs an Out-Licensing Agreement with Novartis for M6495 (Anti-ADAMTS5 Nanobody) for Osteoarthritis  

Published: Oct 7, 2020 | Tags: Ablynx, Anti-ADAMTS5 Nanobody, Merck, Novartis, Osteoarthritis, Out-Licensing Agreement

Samsung Bioepis and Biogen Announce EMA Filling Acceptance of SB11 (biosimilar, Lucentis)  

Published: Oct 7, 2020 | Tags: Biogen, Biosimilar, EMA Filling, Lucentis, Ophthalmology, Samsung Bioepis, SB11

Exact Sciences and Pfizer Announce Extension and Amendment of their Cologuard Promotion Agreement  

Published: Oct 7, 2020 | Tags: Agreement, Amend, Cologuard, Exact Sciences, Extend, Pfizer, Promotion, Signs

Santhera Halts P-III SIDEROS Study Evaluating Puldysa in Patients with DMD     

Published: Oct 6, 2020 | Tags: Discontinue, Duchenne Muscular Dystrophy (DMD), Idebenone, Puldysa, Santhera

 GSK and AstraZeneca Plan to Deploy NVIDIA’s Supercomputer for Drug Development  

Published: Oct 6, 2020 | Tags: AstraZeneca, Deploy, Drug Development, GSK, NVIDIA, Plan, Supercomputer

Amgen Report Results of Sotorasib in P-II CodeBreaK 100 Study for Advanced Non-Small Cell Lung Cancer

Published: Oct 6, 2020 | Tags: Amgen, CodeBreaK 100 clinical study, Investigational KRAS G12C Inhibitor, NSCLC, Sotorasib

Novartis Reports Results of Beovu (brolucizumab) in Two New Post-Hoc Analyses of P-III HAWK and HARRIER Studies for Wet AMD

Published: Oct 6, 2020 | Tags: Beovu, Brolucizumab, EURETINA 2020 virtual congress, HAWK and HARRIER clinical trials, Novartis, P-III, wet AMD patients

Qiagen to Launch Viral RNA Epidemiology Test for COVID-19 and Other RNA Viruses  

Published: Oct 6, 2020 | Tags: Accelerates, COVID-19, Kit, Launch, Novel, PCR Analysis, Qiagen, Simplifies, Testing Portfolio

Pfizer Signs an Agreement with SpringWorks to Evaluate Nirogacestat + PF‐06863135 for R/R Multiple Myeloma 

Published: Oct 6, 2020 | Tags: Agreement, Collaboration, Evaluate, Nirogacestat + PF‐06863135, patients, Pfizer, Relapsed or Refractory Multiple Myeloma, Signs, SpringWorks Therapeutics

GSK’s Zejula (niraparib) Receives Health Canada Approval for 1L Treatment of Women with Advanced Ovarian Cancer 

Published: Oct 6, 2020 | Tags: 1L, Advanced Ovarian Cancer, approval, GSK, Health Canada, niraparib, receives, Treatment, Women, Zejula

Novartis Reports Results of Zolgensma in P-III STR1VE-EU Study for SMA Type 1 

Published: Oct 5, 2020 | Tags: Novartis, P-III STR1VE-EU Study, reports, results, Spinal Muscular Atrophy Type 1, Zolgensma

Amgen Report Five Year Data of Aimovig (erenumab-aooe) in Open-Label Treatment Period of P-II Study for Episodic Migraine 

Published: Oct 5,2020 | Tags: Aimovig, Amgen, Dual Study, erenumab-aooe, P-ll, Report, Result

AstraZeneca’s Farxiga Receives the US FDA’s Breakthrough Therapy Designation for Chronic Kidney Disease 

Published: Oct 5, 2020 | Tags: AstraZenca, Breakthrough Therapy Designation, Chronic Kidney Disease, Farxiga, US FDA’s

AstraZeneca Resumes Clinical Study of its COVID-19 Vaccine in Japan

Published: Oct 5, 2020 | Tags: AstraZeneca, Clinical Study, Covid-19 Vaccine, Resumes

BMS to Acquire MyoKardia for ~$13.1B 

 Published: Oct 5, 2020 | Tags: ~$13.1B, Acquire, BMS, MyoKardia

STADA Expands its Specialty Footprint with the Acquisition of Lobsor Pharmaceuticals

 Published: Oct 5, 2020 | Tags: Acquires, Advanced, Footprint, Innovative Therapy, Lobsor Pharmaceuticals, Parkinson’s Disease, Specialty Pharmaceuticals, STADA, Strengthen, Treating

Related News: PharmaShots Weekly Snapshot (Sept 28 – Oct 1, 2020)

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post